Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Five-Year Optical Coherence Tomography in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents.
Gomez-Lara J, Brugaletta S, Jacobi F, Ortega-Paz L, Ñato M, Roura G, Romaguera R, Ferreiro JL, Teruel L, Gracida M, Martin-Yuste V, Freixa X, Masotti M, Gomez-Hospital JA, Sabate M, Cequier A. Gomez-Lara J, et al. Circ Cardiovasc Interv. 2016 Oct;9(10):e003670. doi: 10.1161/CIRCINTERVENTIONS.116.003670. Circ Cardiovasc Interv. 2016. PMID: 27702766 Clinical Trial.
Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, Gómez-Hospital JA, Alfonso F, Hernández-Antolín R, Goicolea J, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C; DIABETES Investigators. Sabaté M, et al. Circulation. 2005 Oct 4;112(14):2175-83. doi: 10.1161/CIRCULATIONAHA.105.562421. Circulation. 2005. PMID: 16203930 Clinical Trial.
Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Costa MA, Alfonso F, Gómez-Hospital JA, Hernández-Antolín R, Bañuelos C, Goicolea J, Fernández-Avilés F, Bass T, Escaned J, Moreno R, Fernández C, Macaya C; DIABETES Investigators. Jiménez-Quevedo P, et al. J Am Coll Cardiol. 2006 Jun 6;47(11):2172-9. doi: 10.1016/j.jacc.2006.01.063. Epub 2006 May 15. J Am Coll Cardiol. 2006. PMID: 16750681 Free article. Clinical Trial.
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández-Antolín R, SanMartín M, Gómez-Hospital JA, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C; DIABETES Investigators. Jiménez-Quevedo P, et al. Eur Heart J. 2007 Aug;28(16):1946-52. doi: 10.1093/eurheartj/ehm197. Epub 2007 Jun 11. Eur Heart J. 2007. PMID: 17562666 Clinical Trial.
Acute coronary syndromes.
Cequier A, Gómez-Hospital JA, Gonzalez-Costello J. Cequier A, et al. N Engl J Med. 2009 Aug 27;361(9):926; author reply 927. N Engl J Med. 2009. PMID: 19714783 No abstract available.
Drug-eluting stents for off-label indications in real clinical world: evidence based or 'intuition' based clinical practice?
Ribera A, Ferreira-González I, Del Blanco BG, Marsal JR, Cascant P, Martí G, Cequier AR, Gómez-Hospital JA, Fernandez-Nofrerías E, Carrillo X, López-Pérez MC, Navarro J, Raso R, García-Dorado D, Permanyer-Miralda G; ACDC study investigators. Ribera A, et al. Int J Cardiol. 2013 Mar 20;164(1):116-22. doi: 10.1016/j.ijcard.2011.06.096. Epub 2011 Jul 13. Int J Cardiol. 2013. PMID: 21741713
178 results